Discontinued — last reported Q4 '25
Medtronic Medical Surgical — Segment operating profit decreased by 6.0% to $499.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 34.8%, from $765.00M to $499.00M. Over 2 years (FY 2021 to FY 2023), Medical Surgical — Segment operating profit shows relatively stable performance with a -2.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved pricing power, better cost management, or higher sales volume within the surgical portfolio, while a decrease may indicate margin compression, increased competition, or rising operational costs.
This metric represents the operating income generated by the medical surgical business segment after deducting direct op...
Comparable to segment-level operating income reported by diversified medical device peers, though variations exist based on how companies allocate shared corporate expenses.
mdt_segment_medical_surgical_segment_operating_profit| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $901.00M | $914.00M | $908.00M | $923.00M | $827.00M | $642.00M | $714.00M | $748.00M | $752.00M | $719.00M | $790.00M | $806.00M | $690.00M | $774.00M | $765.00M | $494.00M | $531.00M | $499.00M |
| QoQ Change | — | +1.4% | -0.7% | +1.7% | -10.4% | -22.4% | +11.2% | +4.8% | +0.5% | -4.4% | +9.9% | +2.0% | -14.4% | +12.2% | -1.2% | -35.4% | +7.5% | -6.0% |
| YoY Change | — | — | — | — | -8.2% | -29.8% | -21.4% | -19.0% | -9.1% | +12.0% | +10.6% | +7.8% | -4.0% | -2.0% | -5.1% | -28.4% | -31.4% | -34.8% |